{
  "bio": [
    "Hu Kaijun is the president of China Grand Enterprises, whose interests span healthcare, real estate, agriculture and financial services.",
    "China Grand is the parent of three publicly-traded companies: Grand Pharmaceutical, wholesaler Huadong Medicine and Grand Industrial Holding, a trading business.",
    "Grand Pharmaceutical agreed to buy 87.5% of U.S.-based vascular drug maker BlackSwan Vascular for $37.5 million in April 2023."
  ],
  "about": []
}